Kelu Zhou
Impact in
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Retinal Diseases and Treatments 16
- Glaucoma and retinal disorders 4
-
- Peroxisome Proliferator-Activated Receptors 6
- Retinal Development and Disorders 5
- Wnt/β-catenin signaling in development and cancer 3
- Co-authors
- Jian‐xing Ma (26 shared papers)Yang Hu (7 shared papers)Fangfang Qiu (8 shared papers)Kyoungmin Park (4 shared papers)Bin Zhang (2 shared papers)Yusuke Takahashi (3 shared papers)Rui Cheng (11 shared papers)Ti Zhou (2 shared papers)
- Journals
- Diabetes (7 papers)Investigative Ophthalmology & Visual Science (6 papers)PLoS ONE (3 papers)Diabetologia (3 papers)American Journal Of Pathology (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Kelu Zhou
31 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Ophthalmology 523
- Clinical Biochemistry 96
- Neurology 92
- Cancer Research 158
- Radiology, Nuclear Medicine and Imaging 208
Countries citing papers authored by Kelu Zhou
This map shows the geographic impact of Kelu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelu Zhou more than expected).
Fields of papers citing papers by Kelu Zhou
This network shows the impact of papers produced by Kelu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelu Zhou. The network helps show where Kelu Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelu Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 132 | |
| 2 | 2011 | 111 | |
| 3 | 2019 | 101 | |
| 4 | 2010 | 92 | |
| 5 | 2013 | 84 | |
| 6 | 2010 | 81 | |
| 7 | 2010 | 77 | |
| 8 | 2010 | 71 | |
| 9 | 2011 | 69 | |
| 10 | 2013 | 49 | |
| 11 | 2017 | 47 | |
| 12 | 2009 | 43 | |
| 13 | 2021 | 42 | |
| 14 | 2017 | 42 | |
| 15 | 2011 | 38 | |
| 16 | 2019 | 37 | |
| 17 | 2019 | 37 | |
| 18 | 2017 | 32 | |
| 19 | 2020 | 29 | |
| 20 | 2020 | 28 |
About Kelu Zhou
Kelu Zhou is a scholar working on Ophthalmology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Genetics and Cancer Research, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (16 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Retinal Development and Disorders (5 papers), Glaucoma and retinal disorders (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Retinal Imaging and Analysis (3 papers), Retinopathy of Prematurity Studies (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Ophthalmology (523 citations), Clinical Biochemistry (96 citations), Neurology (92 citations), Cancer Research (158 citations) and Radiology, Nuclear Medicine and Imaging (208 citations). Kelu Zhou has collaborated with scholars based in United States, China and France. Frequent co-authors include Jian‐xing Ma, Yang Hu, Fangfang Qiu, Kyoungmin Park, Bin Zhang, Yusuke Takahashi, Rui Cheng, Ti Zhou, Ying Chen and Elizabeth Moran. Their work appears in journals such as Diabetes, Investigative Ophthalmology & Visual Science, PLoS ONE, Diabetologia and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.